HuGE Literature Finder
|
||
Records 1-10
|
Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease.
Leukemia research 2017 Jun 60 18-23. Barosi Giovanni, Massa Margherita, Campanelli Rita, Fois Gabriela, Catarsi Paolo, Viarengo Gianluca, Villani Laura, Poletto Valentina, Bosoni Tiziana, Magrini Umberto, Gale Robert P, Rosti Vittor |
|
Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid.
The Journal of molecular diagnostics : JMD 2017 May . Mehrotra Meenakshi, Singh Rajesh R, Chen Wei, Huang Richard S P, Almohammedsalim Alaa A, Barkoh Bedia A, Simien Crystal M, Hernandez Marcos, Behrens Carmen, Patel Keyur P, Routbort Mark J, Broaddus Russell R, Medeiros L Jeffrey, Wistuba Ignacio I, Kopetz Scott, Luthra Rajyalaksh |
|
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Oncotarget 2016 Jul . Palomo Laura, Garcia Olga, Arnan Montse, Xicoy Blanca, Fuster Francisco, Cabezón Marta, Coll Rosa, Ademà Vera, Grau Javier, Jiménez Maria-José, Pomares Helena, Marcé Sílvia, Mallo Mar, Millá Fuensanta, Alonso Esther, Sureda Anna, Gallardo David, Feliu Evarist, Ribera Josep-Maria, Solé Francesc, Zamora Lurd |
|
Epidemiology and clinical relevance of mutations in post-polycythemia vera and post-essential thrombocythemia myelofibrosis. A study on 359 patients of the AGIMM group.
American journal of hematology 2016 Apr . Rotunno Giada, Pacilli Annalisa, Artusi Valentina, Rumi Elisa, Maffioli Margherita, Delaini Federica, Brogi Giada, Fanelli Tiziana, Pancrazzi Alessandro, Pietra Daniela, Bernardis Isabella, Belotti Clara, Pieri Lisa, Sant'Antonio Emanuela, Salmoiraghi Silvia, Cilloni Daniela, Rambaldi Alessandro, Passamonti Francesco, Barbui Tiziano, Manfredini Rossella, Cazzola Mario, Tagliafico Enrico, Vannucchi Alessandro M, Guglielmelli Pao |
|
A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients.
Pharmacogenomics 2014 Apr 15 (5): 609-18. Maftouh Mina, Avan Amir, Funel Niccola, Paolicchi Elisa, Vasile Enrico, Pacetti Paola, Vaccaro Vanja, Faviana Pinuccia, Campani Daniela, Caponi Sara, Mambrini Andrea, Boggi Ugo, Cantore Maurizio, Milella Michele, Peters Godefridus J, Reni Michele, Giovannetti Eli |
|
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.
American journal of hematology 2014 Feb 89 (2): 181-6. Hou Hsin-An, Kuo Yuan-Yeh, Tang Jih-Luh, Chou Wen-Chien, Yao Ming, Lai Yan-Jun, Lin Chien-Chin, Chen Chien-Yuan, Liu Chieh-Yu, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Huang Shang-Yi, Ko Bor-Sheng, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
|
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome.
Blood cancer journal 2014 4 e177. Chen T-C, Hou H-A, Chou W-C, Tang J-L, Kuo Y-Y, Chen C-Y, Tseng M-H, Huang C-F, Lai Y-J, Chiang Y-C, Lee F-Y, Liu M-C, Liu C-W, Liu C-Y, Yao M, Huang S-Y, Ko B-S, Hsu S-C, Wu S-J, Tsay W, Chen Y-C, Tien H |
|
Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 Dec 22 (12): 2333-44. Leinonen Katri A, Saramäki Outi R, Furusato Bungo, Kimura Takahiro, Takahashi Hiroyuki, Egawa Shin, Suzuki Hiroyoshi, Keiger Kerri, Ho Hahm Sung, Isaacs William B, Tolonen Teemu T, Stenman Ulf-Håkan, Tammela Teuvo L J, Nykter Matti, Bova G Steven, Visakorpi Tap |
|
EZH2 mutations are frequent and represent an early event in follicular lymphoma.
Blood 2013 Oct 122 (18): 3165-8. Bödör Csaba, Grossmann Vera, Popov Nikolay, Okosun Jessica, O'Riain Ciarán, Tan King, Marzec Jacek, Araf Shamzah, Wang Jun, Lee Abigail M, Clear Andrew, Montoto Silvia, Matthews Janet, Iqbal Sameena, Rajnai Hajnalka, Rosenwald Andreas, Ott German, Campo Elias, Rimsza Lisa M, Smeland Erlend B, Chan Wing C, Braziel Rita M, Staudt Louis M, Wright George, Lister T Andrew, Elemento Olivier, Hills Robert, Gribben John G, Chelala Claude, Matolcsy András, Kohlmann Alexander, Haferlach Torsten, Gascoyne Randy D, Fitzgibbon Ju |
|
Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma.
PloS one 2013 8 (9): e74870. Yu Yung-Luen, Su Kuo-Jung, Hsieh Yi-Hsien, Lee Hsiang-Lin, Chen Tzy-Yen, Hsiao Pei-Ching, Yang Shun- |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 10, 2019
- Content source: